Get started
Author

Zeni Ramirez

Observed names: Z Ramirez, Z. Ramirez
ORCID: 0000-0001-5566-8049
Observed ORCID: 0000-0001-5566-8049
OpenAlex ID: A5141243935
TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
2026 · Alyssa Stockard, Zachary Leibovit-Reiben, et al. · medRxiv · 1
PDF
LB1162 Deucravacitinib response and single-cell keratinocyte programs in pityriasis rubra pilaris
2026 · S.E. Penner, B.T. Roberts, et al. · Journal of Investigative Dermatology
PDF
LB1086 Deep phenotyping reveals keratinocyte-dominant innate inflammation in bullous pemphigoid
2026 · B.T. Roberts, S.E. Penner, et al. · Journal of Investigative Dermatology
0488 Rapid molecular and clinical improvement in cutaneous dermatomyositis with brepocitinib: Results from a phase 2 trial
2026 · A.R. Mangold, R. Jiang, et al. · Journal of Investigative Dermatology
0477 TYK2 inhibition disrupts pathogenic immune circuits in lichen planopilaris
2026 · A.L. Stockard, R. Jiang, et al. · Journal of Investigative Dermatology
0025 Transcriptomic profiling reveals differential organization of immune programs in treatment-refractory bullous pemphigoid
2026 · B.T. Roberts, S.E. Penner, et al. · Journal of Investigative Dermatology
0053 Transcriptomic profiling defines core bullous pemphigoid immune programs and distinct keratinocyte-based signature in immune checkpoint inhibitor–induced disease
2026 · S.E. Penner, B.T. Roberts, et al. · Journal of Investigative Dermatology
0109 Pathtrack: Longitudinal metastasis risk assessment for squamous cell carcinoma
2026 · M. Aouad, A. Choudhary, et al. · Journal of Investigative Dermatology
75318 Deucravacitinib in the Treatment of Pityriasis Rubra Pilaris: A Phase 2 Clinical Trial
2026 · Bryce T. Roberts, Scott Penner, et al. · Journal of the American Academy of Dermatology
77175 Predictors of Treatment Refractory Bullous Pemphigoid
2026 · Scott Penner, Bryce T. Roberts, et al. · Journal of the American Academy of Dermatology
77077 Transcriptomic Analysis of TYK2 Inhibition as a Therapeutic Target in Lichen Planopilaris
2026 · Alyssa L. Stockard, Zachary Leibovit-Reiben, et al. · Journal of the American Academy of Dermatology
Clinical and Molecular Effects of TYK2/JAK1 Inhibition in Dermatomyositis
2026 · AR Mangold, RA Vleugels, et al. · medRxiv
PDF
Works count: 12
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type